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Demographic trends in the Okinawa Dialysis Study (OKIDS) demographics are changing [3–5]. The number of dialysis
registry (1971–2000). patients is dependent, at least partly, on the number of
Background. The clinical demographics of chronic dialysis dialysis beds [6]. In Japan, Okinawa is an area of highpatients are changing worldwide. However, long-term data from
incidence and prevalence of dialysis patients [1, 6]. Sinceregional dialysis registries have not yet been analyzed and
1971, we have registered all chronic dialysis patients re-reported.
Methods. The Okinawa Dialysis Study (OKIDS) registry in- siding in Okinawa and who survived at least one month
cluded all chronic dialysis patients treated in Okinawa, Japan, on scheduled dialysis [4]. The prevalence and incidence
since 1971. Data for the years 1971 to 1990 were analyzed to of dialysis patients and the mean age at the start ofpredict trends for 1991 to 2000. The predicted values were then
dialysis increased linearly from 1971 to 1990. The presentcompared to the actual values and analyzed statistically, with
study extended the observation to 2000 and tested trendsparticular attention being paid to relative risk of death. Multi-
variate Cox proportional hazards analysis was done to analyze on the basis of predictions calculated from the 1971–1990
the time factors of relative risk of death. data. We also compared the Okinawa data with that of
Results. A total of 5246 patients (2981 men and 2265 women) the Japanese Society for Dialysis Therapy (JSDT) reg-were registered and the total duration of observation was
istry [1] to examine geographic differences.28,431 patient-years. The prevalence and incidence of dialysis
Survival rates for ESRD patients differ between coun-patients expressed per million population were 2320 and 297,
respectively, in 2000, values that were significantly higher (P tries and registries. Any comparison that involves sepa-
0.02 for both) than the predicted values. The gross mortality rate registries or different countries must be approached
rate per 1000 patient-years was 118.4 for 1971 to 1980, 63.3 for
with caution [7]. Analysis of long-term regional dialy-1981 to 1990, and 77.7 for 1991 to 2000. The adjusted hazards
sis registry data is suitable for understanding the time-ratio (95% confidence interval) for mortality was 0.743 (0.650
to 0.862) for 1981–1990 and 0.721 (0.659 to 0.790) for 1991 to dependent changes in the demographics of chronic dial-
2000 in comparison to the risk of mortality in 1971 to 1980. The ysis patients.
decrease in mortality rate was largely due to the drop in cardiac
deaths from 71.0 for 1971 to 1980 to 17.2 for 1991 to 2000.
Conclusions. The incidence and prevalence of chronic dial- METHODS
ysis patients increased more than expected over the past decade
Data collection for the OKIDS registryin Okinawa, Japan. Despite the rapid change in patient demo-
graphics, the survival rate did not decrease significantly. All chronic dialysis patients residing in Okinawa, Ja-
pan, who survived at least one month on scheduled di-
alysis were registered in the Okinawa Dialysis Study
The number of patients with end-stage renal disease (OKIDS) registry [4]. Patients dying within one month
(ESRD) requiring chronic dialysis is increasing world- of the start of dialysis were not included in the registry
wide [1, 2]. Patients with predialysis comorbidities, pa- because it is unknown whether their renal function was
tients with diabetes mellitus (DM), and the elderly are improving or other medical conditions accounted for
now accepted into treatment by dialysis, thus the clinical their rapid demise. Pertinent clinical information for the
new dialysis patients and medical events in the prevalent
dialysis patients were recorded via strict collaborationKey words: hemodialysis, peritoneal dialysis, end-stage renal disease,
survival, comorbidity, diabetes mellitus, Japan and dialysis. of physicians who are acknowledged herein. Records
were updated at least twice a year for medical eventsReceived for publication May 30, 2001
such as death, renal transplantation, and patient transferand in revised form September 5, 2001
Accepted for publication September 7, 2001 to outside Okinawa. If needed, other information was
obtained through nurses, medical clerks, and the patients 2002 by the International Society of Nephrology
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themselves. All patients were followed up until a major poietin [1]. By the end of 2000, there were 46 dialysis
medical event or to January 2001, and outcomes were units in Okinawa: 9 in the public sector, 17 in private
verified by us. Since Okinawa is comprised of subtropical hospitals, and 20 in clinics. In the retrospective analysis
islands that are separated from mainland Japan, there for 1971 to 1990, there was a significant linear increase
is little migration of patients. The total population of Oki- in the annual incidence, prevalence and mean age at the
nawa was 1.2 million in 1990 and 1.32 million in 2000, start of dialysis [4]. In the present study, we analyzed
which is approximately 1.0% of the overall population these population measures again and compared the
of Japan. Several retrospective [4, 5, 8, 9] and prospective actual data for 1991 to 2000 with the predicted values
[10–12] studies based on the registry data have been [4]. Twenty patients who were started on chronic dialy-
reported. sis therapy outside Okinawa during 1971 to 1990 became
The present study summarizes data from the past 30 residents after January 1991 and are included in the
years, 1971 to 2000. Patients with intermittent or continu- present study.
ous ambulatory peritoneal dialysis (CAPD) were in-
Dialysis registry of the JSDTcluded in the analysis, because CAPD patients comprise
a very small fraction of the overall population, and they The JSDT has had a standing committee responsible
often switch dialysis modalities. Fewer than 100 CAPD for statistics and investigation since 1983 [1]. The JSDT
patients have participated in OKIDS throughout the mails a survey every year at the end of November to the
study period. Criteria for the differential diagnosis of heads of all dialysis facilities on record. Details of survey
ESRD were neither simple nor standardized. Therefore, method have been described previously [14, 15]. The
the medical records were reviewed further, and patients latest report of the 1999 JSDT registry was used for the
were grouped into one of six disease categories. Chronic present study. In brief, as of December 31, 1999, a total
glomerulonephritis (CGN) was diagnosed when protein- of 3220 out of 3231 units (99.66%) have responded. The
uria and/or hematuria was noted before the onset of total number of dialysis patients was 197,213, up 6.4%
hypertension and renal failure. Nephrosclerosis (NScl) (N  11,891) from the prior year. The mean age of new
was diagnosed when hypertension and/or major vascular dialysis patients was 63.4 years. The primary renal dis-
disease was documented before the onset of renal failure. ease among the new dialysis patients in 1999 was DM
DM nephropathy was diagnosed clinically by a long his- nephropathy in 36.2%, followed by CGN in 33.6%. The
tory of DM, presence of DM retinopathy, and the use mean Kt/V for those on dialysis three times per week
of insulin [8]. Systemic lupus erythematosus (SLE) was was 1.33 (1.25 for men and 1.46 for women), and the
diagnosed according to the criteria of the American
mean dialysis session time was four hours (4.03 hours
Rheumatism Association [9]. Polycystic kidney disease
for men and 3.96 hours for women). The mean serum(PKD) was diagnosed, after chart review, after the pres-
level of albumin was 3.88 g/dL for men and 3.82 g/dLence of multiple cysts and with a family history. A sixth
for women. The mean body mass index of the new dialy-category, “other” disease, was used for patients who did
sis patients was 20.9 kg/m2 for men and 20.2 kg/m2 fornot fall into one of the above-mentioned disease catego-
women.ries. Predialysis comorbidities were confirmed by review
of the medical charts and were grouped into six catego- Statistical analysis
ries: atherosclerotic heart disease (ASHD), peripheral
Annual incidence and prevalence data at each year-vascular disease (PVD), chronic obstructive pulmonary
end were obtained from a government report and aredisease (COPD), malignancies (MAL), cerebrovascular
expressed per million population. The observation pe-disease (CVD), and “other.”
riod was calculated from the start of dialysis until theThe dialysis regimen has been described previously
end of follow-up, death, renal transplantation, or transfer[4, 10]. The mean dialysis dose was around 18.0 m2 
outside Okinawa, and is expressed in patient-years. One-h/week. More than 90% of the patients were receiving
way repeated measures analysis of variance (ANOVA)dialysis at 3.5 or more hours per session. Dialyzer reuse
was used to compare the incidence and prevalence be-does not usually occur in Japan, since the care providers
tween groups. Kaplan-Meier survival curves were calcu-are reluctant to reuse the dialyzer if doing so means they
lated. Patients were censored at the time of death, renalcannot receive government reimbursement [13]. Vascu-
transplantation, transfer outside Okinawa, or Januarylar access usually was created by a surgeon, and the
2001. Multivariate Cox proportional hazards analysis wasarteriovenous (AV) fistula was the preferred access. In
done to examine the relative risk of death by the startour region, we normally wait until the AV fistula has
year of dialysis after adjusting for confounding variablesmatured, and in the interim the patients are dialyzed
such as age, sex, start year of dialysis, primary renal dis-with a temporary catheter. The target hematocrit has been
ease, and predialysis comorbidities. Data are expressedset empirically between 30% and 35%, and more than
80% of the dialysis patients have been given erythro- as mean (SD). All analyses were done using the SAS
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Table 2. Comparison of the number of patients (per millionTable 1. Clinical demographics of chronic dialysis patients in
Okinawa, Japan (1971–2000) population) from 1991–2000 in Okinawa and JSDT
Number of patients 5246 Number of
Men/women 2981/2265 Number of new prevalent
GeneralAge at start of dialysis, years dialysis patients dialysis patients
populationMen mean (SD) 53.6 (16.5)
Year million OKIDS JSDT OKIDS JSDTrange 1 to 101
Women mean (SD) 57.2 (17.6) 1991 1.22 190 169 1251 944
range 1 to 97 1992 1.23 208 181 1346 996
Primary renal disease 1993 1.24 228 191 1445 1076
Chronic glomerulonephritis 2461 (46.9%) 1994 1.25 233 194 1562 1149
Diabetes mellitus 1603 (30.6%) 1995 1.26 224 210 1661 1230
Nephrosclerosis 535 (10.2%) 1996 1.27 258 226 1760 1328
Systemic lupus erythematosus 111 (2.1%) 1997 1.28 295 229 1926 1395
Polycystic kidney disease 123 (2.3%) 1998 1.29 292 234 2071 1465
Others 413 (7.9%) 1999 1.30 315 249 2227 1557
Predialysis comorbid condition 2000 1.32 297 252 2320 1624
Atherosclerotic heart disease 206 (3.9%)
Abbreviations are: OKIDS, Okinawa Dialysis Study; JSDT, Japanese SocietyChronic obstructive lung disease 71 (1.4%)
for Dialysis Therapy; NA, data not available.Cerebrovascular disease 296 (5.6%)
Peripheral vascular disease 90 (1.7%)
Malignancies 157 (3.0%)
Others 185 (3.5%)
Current status in January 2001 among patients with chronic glomerulonephritis, DM,Alive on dialysis 2840 (54.1%)
nephrosclerosis, and “other” diseases. However, no sexDied 2137 (40.7%)
Renal transplantation 208 (4.0%) differences in mean age at the start of dialysis were found
Transferred outside 61 (1.2%)
among patients with SLE or PKD.
Changes in prevalence of dialysis patients in the three
decades are shown according to age categories in Fig-
ure 1. For 1971 to 1980, there was no noticeable differ-software (SAS, Chicago, IL, USA). P 0.05 was consid-
ence between age groups. However, the prevalence in-ered statistically significant.
creased with age in the second and third ten-year periods.
Changes in prevalence of dialysis patient are shown per
RESULTS primary renal disease in Figure 2. For 1971 to 1980, CGN
Over the 30-year period, 5246 patients (2981 men and was the main cause of ESRD. For 1981 to 1990, both
2265 women) were treated in Okinawa. The clinical de- CGN and DM contributed to the increase in the treat-
mographics of the OKIDS registry patients are summa- ment rate. Between 1991 and 2000, DM and NScl con-
rized in Table 1. The overall mean (SD) age at the start tributed to the further increase. The contribution of
of dialysis was 55.1 (17.1) years and ranged from 1 to CGN did not change remarkably between the second
101 years. Total observation was 28,431 patient-years. and third ten-year periods. However, the average age at
Comorbid conditions existed in 5.6% of patients for 1971 the start of dialysis increased from 46.4 years in the
to 1980, 15.5% for 1981 to 1990, and 22.7% for 1991 to second decade to 53.8 years in the third decade.
2000. During the period of 1991 to 2000, the observed Survival curves by decades of starting dialysis are
incidence and prevalence of dialysis patients were sig-
shown in Figure 3. The overall survival rate was 88.6%
nificantly higher (P  0.02 for both) than predicted. The
for one year, 66.5% for five years, 48.2% for ten years,predicted incidence and prevalence of dialysis patients
and 29.3% for 20 years. Survival rates were significantlywere from 183 and 1291 in 1991 to 266 and 2068 in
influenced by age at the start of dialysis (Fig. 4), predial-1999, respectively. In comparison to the JSDT data, both
ysis comorbidities (Fig. 5), and primary renal diseasesincidence and prevalence were significantly high in Oki-
(Fig. 6). Effects of confounding variables such as startnawa (P  0.01 for both; Table 2).
year, primary renal disease, and predialysis comorbidit-The mean age at the start of dialysis increased from
ies are summarized in Table 3. Patients with PKD had55.9 years in 1991 to 61.4 years in 1999, but the predicted
comparable survival to patients with CGN.ages for 1991 to 1999 were 58.0 years to 69.3 years and
Changes in the causes of death and mortality rates for58.2 years to 63.4 years (JSDT). The mean age of OKIDS
each decade are shown in Figure 7. The overall deathSLE patients (37.9 years) and the mean age of OKIDS
rate was 75.2 per 1,000 patient-years for the past 30 years.PKD patients (53.4 years) were lower than the mean
Cardiac death decreased sharply for 1981 to 1990, andages of JSDT SLE patients (53.1 years), and JSDT PKD
a similar trend occurred for 1991 to 2000. For 1991 topatients (58.0 years). With the exception of 1971 to 1980,
2000, deaths due to withdrawal from dialysis and infec-there were significant sex differences in mean age at the
start of dialysis. Men started dialysis earlier than women tion increased slightly.
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Fig. 1. Prevalence of chronic dialysis patient
per 10,000 population shown by age categories
for three 10-year periods. Symbols for the age
ranges are: () 39; ( ) 40 to 49; ( ) 50 to
59; ( ) 60 to 69; () 70.
Fig. 2. Prevalence of chronic dialysis patient
per 10,000 population shown by primary renal
disease for 10-year periods.
DISCUSSION values at the start of dialysis decreased only slightly from
14.3 mg/dL during 1971 to 1981 to 12.0 mg/dL for 1988The present study documents clinical demographic
to 1990 [16]. This subtle decrease in incident creatininechanges traced through over three decades via a regional
values may be explained by a concurrent increase in thedialysis registry. The incidence and prevalence of chronic
number of older and sicker patients [17]. Given the lowdialysis patients increased more than expected. Usami
rate of renal transplantation (6.5 to 9.1 per 1000 patient-et al showed the number of available dialysis beds to be
years during the study period) and CAPD (Table 1), thecorrelated with the number of dialysis patients, but this
present study fairly accurately shows the overall changeswas not considered a causative factor [6]; in fact, there
in hemodialysis therapy for the past three decades inare more dialysis units per capita in Okinawa (35.1 per
Okinawa, Japan.million population) in comparison to the JSDT data (25.4
The reasons why the incidence of ESRD has increasedper million population) [1]. However, this does not nec-
so rapidly are not clear, but several possibilities exist.essarily mean that the criteria for initiating dialysis are
subject to change. Actually, the mean serum creatinine First, the low birth weight (less than 2500 grams) rate
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Fig. 3. Survival curves, calculated by the Kaplan-Meier method, by the Fig. 5. Survival curves, calculated by the Kaplan-Meier method, by pre-
start year of dialysis. dialysis comorbidities. Abbreviations are: MAL, malignancies; ASHD,
atherosclerotic heart disease; COPD, chronic obstructive pulmonary dis-
ease; PVD, peripheral vascular disease; CVD, cerebrovascular disease.
Fig. 4. Survival curves, calculated by the Kaplan-Meier method, by
age at the start of dialysis.
Fig. 6. Survival curves, calculated by the Kaplan-Meier method, by pri-in Okinawa has been as high as 7.4% to 9.3%, which is
mary renal disease. Abbreviations are: PKD, polycystic kidney disease;higher than the national average of 5.7%. Low birth CGN, chronic glomerulonephritis; SLE, systemic lupus erythematosus;
weight has been linked to later development of hyperten- Nscl, nephrosclerosis; DM, diabetes mellitus.
sion and renal failure [18]. Second, patients do not always
comply with their medical treatments. Our previous
study screened a cohort and found that those who were
then, the people of Okinawa have undergone a markedscreened and found to be at risk of developing ESRD
change in lifestyle and dietary habits. An increase in DMwere not treated accordingly [19, 20]. Data from USRDS
nephropathy has been reported recently in indigenousindicated that only 42% had permanent vascular access
populations [24, 25].attempted before ESRD treatment [21]. Therefore, late
The mean age at the start of dialysis was lower in thereferral to a nephrologist is considered common not only
OKIDS patients than in the JSDT patients. In particular,in Okinawa but also worldwide [22]; however, whether
the OKIDS patients with SLE and PKD were signifi-progression of kidney disease is indeed slowed by the
cantly younger than their JSDT counterparts. Therenephrologist’s intervention remains to be determined
were no sex differences in mean age at start of dialysis[23]. Third, the incidence of DM has increased rapidly.
among patients with PKD. In contrast, Ishikawa et alMore than one-third of the new dialysis patients were
showed that mean age at start of dialysis was youngerstarted because of DM, mostly non-insulin dependent
in JSDT men than in JSDT women [26]. Konoshita etDM. Okinawa reverted to Japan in 1972 after U.S. mili-
tary rule that began at the end of World War II. Since al showed that patients with PKD homozygous for the
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Table 3. Results of the multivariate Cox proportional hazards analysis for the prognosis of chronic dialysis patients
Adjusteda hazards ratio 95% CI P value
Sex
Women 1.000
Men 1.141 1.046–1.245 0.0028
Start year of dialysis
1971–1980 1.000
1981–1990 0.743 0.650–0.862 0.0001
1991–2000 0.721 0.659–0.790 0.0001
Age at start of dialysis years
0–49 1.000
50–59 2.587 2.252–2.972 0.0001
60–69 2.066 1.926–2.217 0.0001
70–79 1.955 1.853–2.063 0.0001
80 1.799 1.706–1.897 0.0001
Primary renal disease
Chronic glomerulonephritis 1.000
Diabetes mellitus 2.225 1.985–2.495 0.0001
Polycystic kidney disease 0.869 0.724–1.043 NS
Systemic lupus erythematosus 1.328 1.220–1.445 0.0001
Nephrosclerosis 1.054 1.021–1.088 0.0013
Other 1.151 1.092–1.214 0.0001
Predialysis comorbid condition
None 1.000
Atherosclerotic heart disease 1.549 1.272–1.886 0.0001
Chronic obstructive pulmonary disease 1.181 1.011–1.380 0.0364
Peripheral vascular disease 1.214 1.104–1.335 0.0001
Malignancies 1.198 1.141–1.258 0.0001
Cerebrovascular disease 1.038 1.008–1.068 0.0122
Other 1.125 1.079–1.172 0.0001
a Adjusted for variables in this table; NS denotes not significant
Fig. 7. Causes of death and mortality rates for
each decade. Mortality rate is expressed as the
number of deaths per 1000 patient-years.
D allele of the ACE gene are at increased risk for devel- positive outcomes are not certain; however, we speculate
that more emphasis on salt restriction and blood pressureoping ESRD at an early age [27]. In this regard, it is
possible that the ACE genotype differs in Okinawa, since control, the introduction of erythropoietin, and access
to better cardiac care are contributing factors. Accordinganalysis of HLA gene polymorphism suggests a gene
flow from Okinawa to mainland Japan [28]. to the JSDT registry, the ten-year survival rate for
chronic dialysis patients who started dialysis after 1983The overall survival rate among chronic dialysis pa-
tients in Okinawa has been good at 48.2% in 10 years. was 0.490 in Okinawa, whereas the national average was
0.423 [1]. In general, Japanese people live longer thanCardiac death remained a leading cause of death, but it
decreased significantly (Fig. 7). The exact reasons for the those of other countries [29], and Okinawa is the region
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of Japan where the overall population’s lifespan is the treatment are similar between Japan (¥442,056) and the
United States ($3,683.4) [13].longest, particularly for women. The annual incidence of
acute myocardial infarction and stroke death is reported Renal transplantation rates remained low during the
three decades, but the reasons are not clear. Given theat 31 and 137 per 100,000 population in Okinawa [30].
Therefore, survival rates in dialysis patients may reflect greater age at the start of dialysis and the difficulty in
obtaining a graft, xenotransplantation may be a hopefulthat of the Okinawa population in general. We showed
the prevalence of hospitalization to be 13% by a cross- alternative. If current trends continue, there will be 400
new dialysis patients and 4000 prevalent dialysis patientssectional study in 1997 [31]. The leading causes of hospi-
talization were stroke, infection, and cardiac disease. So- per million population in Okinawa, surpassing the aver-
age worldwide trends [35].cial causes without major medical reasons accounted for
about 18% of the total hospitalizations. If any of these The incidence and prevalence of chronic dialysis pa-
tients increased faster than expected during the past tenpatients had received social support from a spouse, fam-
ily member, or community members, they could have years in Okinawa, Japan. Despite the increase in elderly
patients and patients with multiple comorbid conditions,undergone chronic dialysis therapy as out-patients.
There are some limitations to the present study. Both the survival rates among dialysis patents did not decline
significantly. In fact, the prognosis of diabetic dialysisthe OKIDS and JSDT data were provided voluntarily from
the participating facilities. Studies looking at the relia- patients has improved significantly [36]. The social and
economic burden of chronic dialysis therapy is increas-bility and validity of the JSDT data are currently under-
way. Although neither registry is likely to be perfect, ing. The social system may become hard pressed to con-
tinue covering these associated costs over the next de-the OKIDS registry is supplemented with additional in-
formation obtained directly from service providers. The cade. More efforts for early detection and treatment of
those who are at risk of developing ESRD are neededUSRDS collected data from billing information of the
Health Care Financing Administration (HCFA) [32], to decrease the number of dialysis patients.
an entirely different source than the OKIDS and JSDT
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Finally, our explanation for the rapid increase in the
incidence of chronic dialysis remains speculative. The peo-
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